Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
      Description

      This study evaluates the ability of tamoxifen to improve frequent or prolonged bleeding in new users of the 52mg levonorgestrel-releasing intrauterine device (IUD). Half of participants will receive a course of tamoxifen three weeks after insertion of the IUD, while the other half of participants will receive a course of placebo.

      Conditions
      MenorrhagiaMetrorrhagiaMedicated Intrauterine Devices
      Talk to us